Clinical Trial

Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective study designed to evaluate the efficacy of a multi-target fecal DNA test for the early detection of gastric cancer. The test combines Helicobacter pylori gene detection with analysis of fecal methylated DNA markers. The primary objective is to assess whether each method, individually or in combination, can facilitate earlier diagnosis of gastric cancer. All participants will undergo the multi-target fecal DNA test and complete the gastric cancer risk questionnaire.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-22; most recent amendment 2026-02-23.
Status change: Not Yet Recruiting → Recruiting 2026-02-23
Trial Details
NCT Number NCT06943807
Lead Sponsor Fudan University
Conditions Gastric (Stomach) Cancer
Enrollment 15,000 participants
Start Date 2025-07-01
Primary Completion 2026-08-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-25